Cam on CaMKII and heart failure research

At the DGK Annual Meeting 2023, Prof. Donald M. Bers, University of California, Davis, reports on his research on the pleitropic enzyme CaMKII, which is involved in various pathological processes in the body. He also talks about possible therapeutic approaches and other research topics he is working on.

Von: Romy Martínez

26.07.2023


Video interview: Heart failure research

with Prof. Donald M. Bers, University of California, Davis, School of Medicine, USA

Related Links

Prof. Mark Anderson, University of Chicago Medical Center, about his research on inhibitors of the protein kinase CaMKII and transatlantic research collaborations.

Link to the online portal of the 89th Annual Meeting

Here you will find the videos of the DGK Annual Meeting 2023.
Access is restricted to DGK members and conference attendees. You don't have a DGK membership yet? Learn more about the benefits of being a DGK member.

Das könnte Sie auch interessieren

Neuartiger Bioadaptor-Stent verspricht langfristigen Vorteil

ESC-Kongress 2024 | INFINITY-SWEDEHEART: Die Studienergebnisse belegen die Effektivität einer neuen Stenttechnologie. Von PD Dr. L. Gaede.

DCB schlechter als DES in De-novo-Läsionen

ESC-Kongress 2024 | REC-CAGEFREE I: Drug-Coated Balloons (DCB) im Vergleich zu konventionellen Drug-Eluting Stents (DES). Von PD Dr. L. Gaede.

Erneut Vorteil für intravaskuläre Bildgebung bei komplexer PCI

ESC-Kongress 2024 | OCCUPI: Einsatz optischer Kohärenztomographie (OCT) bei komplexen Interventionen liefert positive Ergebnisse. Von PD Dr. L. Gaede.

Laden, bitte warten.
Diese Seite teilen